Familial selective IgA deficiency with circulating anti-IgA antibodies: A distinct group of patients?

1991 ◽  
Vol 58 (1) ◽  
pp. 92-101 ◽  
Author(s):  
P.C.J. de Laat ◽  
C.M.R. Weemes ◽  
J.A.J.M. Bakkeren ◽  
F.C.A. van den Brandt ◽  
T.G.P.M. van Lith ◽  
...  
Author(s):  
Isabella Quinti ◽  
Eva Piano Mortari ◽  
Ane Fernandez Salinas ◽  
Cinzia Milito ◽  
Rita Carsetti

A large repertoire of IgA is produced by B lymphocytes with T-independent and T-dependent mechanisms useful in defense against pathogenic microorganisms and to reduce immune activation. IgA is active against several pathogens, including rotavirus, poliovirus, influenza virus, and SARS-CoV-2. It protects the epithelial barriers from pathogens and modulates excessive immune responses in inflammatory diseases. An early SARS-CoV-2 specific humoral response is dominated by IgA antibodies responses greatly contributing to virus neutralization. The lack of anti-SARS-Cov-2 IgA and secretory IgA (sIgA) might represent a possible cause of COVID-19 severity, vaccine failure, and possible cause of prolonged viral shedding in patients with Primary Antibody Deficiencies, including patients with Selective IgA Deficiency. Differently from other primary antibody deficiency entities, Selective IgA Deficiency occurs in the vast majority of patients as an asymptomatic condition, and it is often an unrecognized, Studies are needed to clarify the open questions raised by possible consequences of a lack of an IgA response to SARS-CoV-2.


1986 ◽  
Vol 9 (6) ◽  
pp. 507-513
Author(s):  
Naomi Wakasugi ◽  
Takayoshi Satoh ◽  
Naohiro Ozawa ◽  
Masaru Shimizu ◽  
Shigehiko Kamoshita

1988 ◽  
Vol 47 (2) ◽  
pp. 199-207 ◽  
Author(s):  
Antonio Ferreira ◽  
Maria Cruz Garcia Rodriguez ◽  
Margarita Lopez-Trascasa ◽  
Dora Pascual Salcedo ◽  
Gumersindo Fontan

1987 ◽  
Vol 10 (3) ◽  
pp. 309-317
Author(s):  
Yukinobu Ichikawa ◽  
Mitsuaki Uchiyama ◽  
Shigeru Arimori ◽  
Junichi Ogawa ◽  
Hiroshi Inoue ◽  
...  

2007 ◽  
Vol 39 (4) ◽  
pp. 430-431 ◽  
Author(s):  
Emanuela Castigli ◽  
Stephen Wilson ◽  
Lilit Garibyan ◽  
Rima Rachid ◽  
Francisco Bonilla ◽  
...  

1996 ◽  
Vol 10 (1) ◽  
pp. 57-61 ◽  
Author(s):  
J.W. Sleasman

There is a paradoxical relationship between immunodeficiency diseases and autoimmunity. While not all individuals with immunodeficiency develop autoimmunity, nor are all individuals with autoimmunity immunodeficient, defects within certain components of the immune system carry a high risk for the development of autoimmune disease. Inherited deficiencies of the complement system have a high incidence of systemic lupus erythematosus (SLE), glomerulonephritis, and vasculitis. Carrier mothers of children with chronic granulomatous disease, an X-linked defect of phagocytosis, often develop discoid lupus. Several antibody deficiencies are associated with autoimmune disease. Autoimmune cytopenias are commonly observed in individuals with selective IgA deficiency and common variable immune deficiency. Polyarticular arthritis can be seen in children with X-linked agammaglobulinemia. Combined cellular and antibody deficiencies, such as Wiskott-Aldrich syndrome, carry an increased risk for juvenile rheumatoid arthritis and autoimmune hemolytic anemia. Several hypothetical mechanisms have been proposed to explain the associations between autoimmunity and immunodeficiency. Immunologic defects may result in a failure to exclude microbial antigens, resulting in chronic immunologic activation and autoimmune symptoms. There may be shared genetic factors, such as common HLA alleles, which predispose an individual to both autoimmunity and immunodeficiency. Defects within one component of the immune system may alter the way a pathogen induces an immune response and lead to an inflammatory response directed at self-antigens. An understanding of the immunologic defects that contribute to the development of autoimmunity will provide an insight into the pathogenesis of the autoimmune process.


Sign in / Sign up

Export Citation Format

Share Document